$49.2M in expenses

Parker institute for cancer immunotherapy (PICI) encourages advances in cancer immunotherapy research, collaboration, and discovery, and the translation of these advances into cures and treatments for the benefit of patients. To do this, PICI partners with its consortium of preeminent hospitals and academic research centers to conduct its discovery and clinical research and provides its partners with shared research resources, such as scientific equipment, consumables, bioinformatics analysis, and a specimen biobank. PICI also funds and otherwise supports cancer immunotherapy research within its consortium.